P3 Health Partners Inc.
PIII
$6.35
-$0.07-1.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.79% | 18.48% | 25.38% | 23.31% | 25.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.79% | 18.48% | 25.38% | 23.31% | 25.49% |
| Cost of Revenue | 16.39% | 26.29% | 33.50% | 25.39% | 23.61% |
| Gross Profit | -397.63% | -286.24% | -196.89% | -66.22% | 1,991.08% |
| SG&A Expenses | 2.54% | -4.35% | -20.03% | -22.78% | -29.02% |
| Depreciation & Amortization | -1.27% | -0.71% | -0.58% | -0.63% | -0.46% |
| Other Operating Expenses | 371.51% | 522.65% | 216.08% | -230.31% | -237.10% |
| Total Operating Expenses | 18.64% | 26.84% | 27.67% | 17.57% | 14.77% |
| Operating Income | -92.13% | -89.84% | -42.95% | 14.62% | 32.84% |
| Income Before Tax | -68.41% | -66.54% | 61.49% | 73.41% | 88.45% |
| Income Tax Expenses | -24.32% | 62.78% | -56.92% | 119.47% | 108.04% |
| Earnings from Continuing Operations | -66.15% | -66.49% | 61.47% | 72.73% | 88.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 43.92% | 35.66% | -71.79% | -79.17% | -90.94% |
| Net Income | -104.58% | -135.14% | 18.71% | 44.07% | 74.97% |
| EBIT | -92.13% | -89.84% | -42.95% | 14.62% | 32.84% |
| EBITDA | -198.26% | -186.43% | -85.19% | 25.15% | 50.96% |
| EPS Basic | -71.32% | -59.32% | 71.99% | 79.50% | 90.93% |
| Normalized Basic EPS | -625.27% | -159.89% | -100.69% | -99.73% | -99.86% |
| EPS Diluted | -20.74% | -16.32% | 54.76% | 63.99% | 85.08% |
| Normalized Diluted EPS | -704.35% | -160.44% | -100.68% | -99.77% | -99.74% |
| Average Basic Shares Outstanding | 26.81% | 41.06% | 74.75% | 108.86% | 174.05% |
| Average Diluted Shares Outstanding | -10.54% | -6.19% | 7.29% | 58.64% | 15.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |